Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Fundam Clin Pharmacol ; 38(4): 695-702, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38378226

ABSTRACT

BACKGROUND: Fish skin mucus contains innate immune factors and acts as the first line of physical or chemical defense against pathogens. OBJECTIVE: The primary aim of this study was to determine the antiviral activity of sea bream (SBr), rainbow trout (RT), and sea bass (SBa) fish skin mucus against herpes simplex virus (HSV)-1. In addition, it was aimed to associate possible antiviral activity with antimicrobial peptides (AMPs) such as cathelicidin, hepcidin, galectin 2, and C10ORF99, whose levels were determined in the mucus. METHODS: The antiviral activity and oxidative/antioxidant status of mucus against HSV-1 virus was evaluated. In addition, AMPs, SOD, and CAT activities, and immunoglobulin M levels were also analyzed in mucus of fish. RESULTS: Antiviral activity mucus of SBr, RT, and SBa against HSV-1 were determined as 2-4, 2-5, and 2-2, respectively. The higher antiviral activity of SBr and RT mucus compared to the mucus of SBa can be associated with higher AMP levels in them. CONCLUSION: The skin mucus of SBr and RT may be nutritional supplement, adjuvant, and a new agent that can potentiate the effects of antimicrobial/antiviral agents.


Subject(s)
Antimicrobial Peptides , Antiviral Agents , Herpesvirus 1, Human , Mucus , Animals , Antiviral Agents/pharmacology , Mucus/metabolism , Antimicrobial Peptides/pharmacology , Herpesvirus 1, Human/drug effects , Bass , Sea Bream/virology , Oncorhynchus mykiss/virology , Skin/drug effects , Skin/metabolism , Fishes , Fish Proteins/pharmacology
2.
Can J Physiol Pharmacol ; 101(9): 475-480, 2023 Sep 01.
Article in English | MEDLINE | ID: mdl-37235885

ABSTRACT

This study aimed to determine the effect of administration of oral vitamins A and E at different doses on plasma and brain concentrations of ivermectin in mice. The study was carried out on 174 Swiss Albino male mice aged 8-10 weeks. After leaving six mice for method validation, the remaining mice were randomly divided into seven groups with equal numbers of animals. Mice received ivermectin (0.2 mg/kg, subcutaneous) alone and in combination with low (vitamin A: 4000 IU/kg; vitamin E: 35 mg/kg) and high (vitamin A: 30 000 IU/kg; vitamin E: 500 mg/kg) oral doses of vitamins A and E. The plasma and brain concentrations of ivermectin were measured using high-performance liquid chromatography-fluorescence detector. We determined that high doses of vitamins A and E and their combinations increased the passing ratio of ivermectin into the brain significantly. The high-dose vitamin E and the combination of high-concentration vitamins E and A significantly increased the plasma concentration of ivermectin (P < 0.05). The high-dose vitamins E and A and their high-dose combination increased the brain concentration of ivermectin by 3, 2, and 2.7 times, respectively. This research is the first in vivo study to determine the interaction between P-gp substrates and vitamins E and A.


Subject(s)
Antiparasitic Agents , Brain , Ivermectin , Vitamin A , Vitamin E , Animals , Mice , Brain/metabolism , Ivermectin/blood , Ivermectin/pharmacokinetics , Vitamin A/administration & dosage , Vitamin E/administration & dosage , Vitamins , Antiparasitic Agents/blood , Antiparasitic Agents/pharmacokinetics
SELECTION OF CITATIONS
SEARCH DETAIL
...